British Journal of Haematology · 1998 · 32 citations · 8 references
Life SciencesHematologyImmunologyCancer ImmunologyCellular ImmunologyImmunotherapyCancer ImmunotherapyCell-based ImmunotherapyDendritic Cell BiologyOncogenic VirusesAdjuvant UseAntigen Presenting CellsDendritic Cell Antigen ProcessingHematologic Malignancy Cell TherapyHuman Herpesvirus 8Myeloma Pathogenesis
Dendritic cells (DC) are antigen-presenting cells with the potential to be a powerful adjuvant in the immunotherapy of haematological malignancy, including myeloma. Recently, human herpesvirus 8 (HHV-8) infection of dendritic cells in the long-term bone marrow stromal cultures of patients with myeloma has been reported. This finding is of great potential importance regarding oncogenesis in myeloma in addition to having significant implications for the use of DC in the immunotherapy of this disease. Therefore DC generated from mobilized blood mononuclear cells (MO-DC) and purified CD34+ cells (CD34-DC) of myeloma patients were examined for the presence of HHV-8 using a sensitive PCR technique. HHV-8 was not demonstrated in MO-DC or CD34-DC and we conclude that these cells remain a suitable vehicle for investigation in the immunotherapy of myeloma.
8
Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma
Yuan Chang, Ethel Cesarman, Melissa S. Pessin et al. · Science · 1994 · 5.7K citations
Proliferating dendritic cell progenitors in human blood.
Nikolaus Romani, Susanne Grüner, D Brang et al. · The Journal of Experimental Medicine · 1994 · 1.9K citations · Full text
Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
Frank J. Hsu, Claudia Benike, Francesco Fagnoni et al. · Nature Medicine · 1996 · 1.8K citations
Medicine, Immunology, Oncology +16